# Aliskiren for Immunoglobulin A (IgA) Nephropathy

> **NCT00870493** · PHASE3 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 22 (actual)

## Conditions studied

- IgA Nephropathy

## Interventions

- **DRUG:** Aliskiren
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00870493
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2012-03
- **Final completion:** 2012-07
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2012-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00870493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00870493, "Aliskiren for Immunoglobulin A (IgA) Nephropathy". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00870493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*